There seems to be a clear commercialisation pathway with Astex and Decitabine in combo.
So assuming Kryprolis is no coincidence then expect Amgen synergy review in the future. We might not see this until after first readouts and proof of concept CPACS.
Two in the running, but need another Amgen, which could be the golden goose!
- Forums
- ASX - By Stock
- Cardioprotection thread
There seems to be a clear commercialisation pathway with Astex...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.44 |
Change
0.040(2.86%) |
Mkt cap ! $245.3M |
Open | High | Low | Value | Volume |
$1.45 | $1.49 | $1.41 | $101.7K | 69.88K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9216 | $1.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.47 | 7767 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9216 | 1.440 |
1 | 1314 | 1.435 |
1 | 10000 | 1.420 |
1 | 4000 | 1.410 |
1 | 711 | 1.405 |
Price($) | Vol. | No. |
---|---|---|
1.465 | 7767 | 2 |
1.480 | 3000 | 1 |
1.510 | 687 | 1 |
1.545 | 2040 | 1 |
1.550 | 5000 | 1 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
NEWS
Is oil undervalued?
RAC (ASX) Chart |